2021-04-28 Senate Journal

Relating to removing FDA approved cannabidiol from schedule V and excluding FDA approved cannabidiol from schedule I.

Submitted by the Controlled Substances Board.

hist132539 Report received from Agency, April 21, 2021.

hist132782 Referred to the committee on Health, April 28, 2021.

Senate Clearinghouse Rule 20-084

Relating to courses of study for and delegation to chiropractic technicians and chiropractic radiological technicians.

Submitted by the Chiropractic Examining Board.

hist132538 Report received from Agency, April 21, 2021.

hist132783 Referred to the committee on Insurance, Licensing and Forestry, April 28, 2021.

Senate Clearinghouse Rule 20-086

Relating to real estate appraisers.

Submitted by the Department of Safety and Professional Services.

hist132537 Report received from Agency, April 21, 2021.

hist132784 Referred to the committee on Insurance, Licensing and Forestry, April 28, 2021.

Senate Clearinghouse Rule 20-087

Relating to furbearer registration and tagging simplification.

Submitted by the Department of Natural Resources.

hist132663 Report received from Agency, April 26, 2021.

hist132781 Referred to the committee on Natural Resources and Energy, April 28, 2021.

Senate Clearinghouse Rule 21-015

Relating to the renewal and reinstatement of licenses.

Submitted by the Psychology Examining Board.

hist132536 Report received from Agency, April 21, 2021.

hist132785 Referred to the committee on Insurance, Licensing and Forestry, April 28, 2021.

_____________

The committee on Health reported and recommended:

Senate Clearinghouse Rule 20-058

Relating to scheduling of Lasmiditan.

hist132776 No action taken on April 26, 2021.

hist132777 Referred to the joint committee for review of Administrative Rules, April 28, 2021.

Senate Clearinghouse Rule 20-075

Relating to scheduling of cenobamate.

hist132774 No action taken on April 26, 2021.

hist132775 Referred to the joint committee for review of Administrative Rules, April 28, 2021.

Senate Clearinghouse Rule 20-076

Relating to scheduling of lemborexant.

hist132772 No action taken on April 26, 2021.

hist132773 Referred to the joint committee for review of Administrative Rules, April 28, 2021.

Senate Clearinghouse Rule 20-078

Relating to scheduling of norfentanyl.

hist132770 No action taken on April 26, 2021.

hist132771 Referred to the joint committee for review of Administrative Rules, April 28, 2021.

Senate Clearinghouse Rule 20-079

Relating to scheduling flualprazolam.

hist132768 No action taken on April 26, 2021.

hist132769 Referred to the joint committee for review of Administrative Rules, April 28, 2021.

PATRICK TESTIN

Chairperson

278